ClinicalTrials.govpublic full text
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)
covid-19, pyramax, pyronaridine, artesunate, corona virus, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 806516
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.